Ana J. Schaefer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana J. Schaefer has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Hannah E. Karpman
Smith College, North Hampton, USA
1 shared publication- John S. Palatucci
Rutgers Center for State Health Policy, Institute for Health, Health Care Policy and Aging Research, The State University of New Jersey, New Brunswick, New Jersey
1 shared publication - Laurel K. Leslie
Mental and Behavioral Health Institute (LK Leslie), Cincinnati Children's, Cincinnati, Ohio
1 shared publication Michael Gusmano
College of Health, Lehigh University, Bethlehem, USA
1 shared publicationStephen Crystal
Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, USA
1 shared publication- Thomas I. Mackie
University of Massachusetts Amherst
1 shared publication
Latest Publications
- Open Access
- 6 August 2022
- Published by Springer Nature in Administration and Policy in Mental Health and Mental Health Services Research
- Vol. 49 (6) , 986-1003
The Role of Formal Policy to Promote Informed Consent of Psychotropic Medications for Youth in Child Welfare Custody: A National Examination
Active participation of youth and surrogate decision-makers in providing informed consent and assent for mental health treatment is critical. However, the procedural elements of an informed consent process, particularly for youth in child welfare custody, are not well defined. Given calls for psychotropic medication oversight for youth in child welfare custody, this study proposes a taxonomy for the procedural elements of informed consent policies based upon formal and informal child welfare policies and then examines whether enacted state formal policies across the United States endorsed these elements. A sequential multi-method study design included: (1) semi-structured interviews with key informants (n = 58) primarily from state child welfare agencies to identify a taxonomy of procedural elements for informed consent of psychotropic medications and then (2) a legislative review of the 50 states and D.C. to characterize whether formal policies endorsed each procedural element through February 2022. Key informants reported five procedural elements in policy, including how to: (1) gather social and medical history, (2) prescribe the medication, (3) authorize its use through consent and youth assent, (4) notify relevant stakeholders, and (5) routinely review the consenting decision. Twenty-three states endorsed relevant legislation; however, only two states specified all five procedural elements. Additionally, the content of a procedural element, when included, varied substantively across policies. Further research and expert consensus are needed to set best practices and guide policymakers in setting policies to advance transparency and accountability for informed consent of mental health treatment among youth in child welfare custody.
- 6 August 2022
- Published by Springer Nature in Administration and Policy in Mental Health and Mental Health Services Research
- Vol. 49 (6) , 986-1003
Open AccessThe Role of Formal Policy to Promote Informed Consent of Psychotropic Medications for Youth in Child Welfare Custody: A National Examination
Active participation of youth and surrogate decision-makers in providing informed consent and assent for mental health treatment is critical. However, the procedural elements of an informed consent process, particularly for youth in child welfare custody, are not well defined. Given calls for psychotropic medication oversight for youth in child welfare custody, this study proposes a taxonomy for the procedural elements of informed consent policies based upon formal and informal child welfare policies and then examines whether enacted state formal policies across the United States endorsed these elements. A sequential multi-method study design included: (1) semi-structured interviews with key informants (n = 58) primarily from state child welfare agencies to identify a taxonomy of procedural elements for informed consent of psychotropic medications and then (2) a legislative review of the 50 states and D.C. to characterize whether formal policies endorsed each procedural element through February 2022. Key informants reported five procedural elements in policy, including how to: (1) gather social and medical history, (2) prescribe the medication, (3) authorize its use through consent and youth assent, (4) notify relevant stakeholders, and (5) routinely review the consenting decision. Twenty-three states endorsed relevant legislation; however, only two states specified all five procedural elements. Additionally, the content of a procedural element, when included, varied substantively across policies. Further research and expert consensus are needed to set best practices and guide policymakers in setting policies to advance transparency and accountability for informed consent of mental health treatment among youth in child welfare custody.